CFO Ronald McClurg to retire June 30, 2026; COO Christopher Volker to succeed as CFO

NEUROONE MEDICAL TECHNOLOGIES Corp

Ronald McClurg to retire as CFO effective June 30, 2026, then serve as Senior Advisor until Dec 31, 2026.
Christopher Volker, current COO, appointed CFO effective July 1, 2026; base salary increased to $350,000.
Volker brings medtech experience from Abbott, CSI, St. Jude Medical; holds Wharton MBA and CFA.
McClurg entered Transition and Release Agreement dated April 28, 2026; will receive salary/benefits through retirement and provide general release.
McClurg's equity awards (options/RSUs) continue per plan terms; no immediate change to equity.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Christopher Volker

Chief Financial Officer

NMTC · NEUROONE MEDICAL TECHNOLOGIES Corp

Effective: 2026-07-01
Filed: April 30, 2026, 7:59 PM ET

the Board announced that Christopher Volker, the Company’s Chief Operating Officer, will succeed Mr. McClurg as the Company’s Chief Financial Officer effective as of July 1, 2026.

Departed

Ronald McClurg

Chief Financial Officer

NMTC · NEUROONE MEDICAL TECHNOLOGIES Corp

Effective: 2026-06-30
Successor: Christopher Volker
Filed: April 30, 2026, 7:59 PM ET

On April 24, 2026, Ronald McClurg notified NeuroOne Medical Technologies Corporation (the "Company") of his intention to retire as the Company’s Chief Financial Officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Christopher Volker was appointed as Chief Financial Officer at NEUROONE MEDICAL TECHNOLOGIES Corp.

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

the Board announced that Christopher Volker, the Company’s Chief Operating Officer, will succeed Mr. McClurg as the Company’s Chief Financial Officer effective as of July 1, 2026.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Ronald McClurg departed as Chief Financial Officer at NEUROONE MEDICAL TECHNOLOGIES Corp.

Action: retire
Role: Chief Financial Officer

Exact text from the filing

On April 24, 2026, Ronald McClurg notified NeuroOne Medical Technologies Corporation (the "Company") of his intention to retire as the Company’s Chief Financial Officer.

View on SEC.gov

NEUROONE MEDICAL TECHNOLOGIES Corp filing history →

Source: SEC EDGAR

accession 0001213900-26-049748

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.